Search

Your search keyword '"Chiller, Tom M."' showing total 387 results
Start Over Author "Chiller, Tom M."
387 results on '"Chiller, Tom M."'

1. Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study

Author

Ribeiro dos Santos, Amanda, Misas, Elizabeth, Min, Brian, Le, Ngoc, Bagal, Ujwal R, Parnell, Lindsay A, Sexton, D Joseph, Lockhart, Shawn R, de Souza Carvalho Melhem, Marcia, Takahashi, Juliana Possatto Fernandes, Oliboni, Gabriel Manzi, Bonfieti, Lucas Xavier, Cappellano, Paola, Sampaio, Jorge Luiz Mello, Araujo, Lisandra Siufi, Alves Filho, Hilton L, Venturini, James, Chiller, Tom M, Litvintseva, Anastasia P, and Chow, Nancy A

Published
2024
Full Text
View/download PDF

5. Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit.

Author

Purdie, Rob, Tushla, Lisa A, Ferretti, Jonathan, Castro, Gonzalo (Kiko), Watson, Ricky, Davis, Thomas, Raborg, Brianna, Mazi, Patrick B, Stroman, Angela, Jones, Carolynn Thomas, Walsh, Thomas J, Chiller, Tom M, Pappas, Peter G, Meyer, John, and Spec, Andrej

Subjects
MYCOSES, REPORTING of diseases, CAREGIVERS, PATIENTS' attitudes, CONSCIOUSNESS raising
Abstract

Background Recently, increasing focus on patient input into research and healthcare improvements has fostered expanded patient-centered advocacy efforts. This first pan-fungal disease summit, part of the MYCology Advocacy, Research, & Education effort, brought together patients, caregivers, and mycology experts to better document patient experiences with invasive fungal disease (IFD) and establish priorities for mycology education, advocacy, and research. Methods Patients who had suffered from IFD, their caregivers, clinicians, industry representatives, government officials, and patient advocacy professionals were invited. Patients and caregivers shared their stories and struggles with IFD. Breakout sessions separated mycology experts from patients and caregivers for further discussions to identify commonalities and perceived gaps and to formulate recommendations. The 2 groups then reconvened to develop consensus recommendations. Results IFD patients and their caregivers shared experiences reflecting the typically lengthy prediagnosis, acute treatment, long-term treatment, and posttreatment recovery stages of IFD. They reported substantial physical, psychological, and financial burdens associated with the IFD experience, particularly related to delayed diagnoses. They reaffirmed a need for coordinated patient-centered education, peer support, and advocacy to document the burden of serious fungal infections. Mycology experts discussed strategies to address gaps in the mycology field, such as insufficient training, inadequate workforce support, and a need to partner more with patient groups. Conclusions A summit involving patients with IFD, family caregivers, and mycology experts identified a substantial nonclinical burden of disease associated with IFD. Patients and mycology experts prioritized several goals for education, advocacy, and research to raise awareness of IFD and improve outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens.

Author

Morris, Arthur J, Kim, Hannah Yejin, Nield, Blake, Dao, Aiken, McMullan, Brendan, Alastruey-Izquierdo, Ana, Colombo, Arnaldo Lopes, Heim, Jutta, Wahyuningsih, Retno, Le, Thuy, Chiller, Tom M, Forastiero, Agustina, Chakrabarti, Arunaloke, Harrison, Thomas S, Bongomin, Felix, Galas, Marcelo, Siswanto, Siswanto, Dagne, Daniel Argaw, Roitberg, Felipe, and Gigante, Valeria

Abstract

The World Health Organization, in response to the growing burden of fungal disease, established a process to develop a fungal pathogen priority list. This systematic review aimed to evaluate the epidemiology and impact of infections caused by Talaromyces marneffei, Coccidioides species, and Paracoccidioides species. PubMed and Web of Sciences databases were searched to identify studies published between 1 January 2011 and 23 February 2021 reporting on mortality, complications and sequelae, antifungal susceptibility, preventability, annual incidence, and trends. Overall, 25, 17, and 6 articles were included for T. marneffei, Coccidioides spp. and Paracoccidioides spp. respectively. Mortality rates were high in those with invasive talaromycosis and paracoccidioidomycosis (up to 21% and 22.7%, respectively). Hospitalization was frequent in those with coccidioidomycosis (up to 84%), and while the duration was short (mean/median 3–7 days), readmission was common (38%). Reduced susceptibility to fluconazole and echinocandins was observed for T. marneffei and Coccidioides spp. whereas >88% of T. marneffei isolates had minimum inhibitory concentration values ≤0.015 μg/ml for itraconazole, posaconazole, and voriconazole. Risk factors for mortality in those with talaromycosis included low CD4 counts (odds ratio 2.90 when CD4 count <200 cells/μl compared with 24.26 when CD4 count <50 cells/μl). Outbreaks of coccidioidomycosis and paracoccidioidomycosis were associated with construction work (relative risk 4.4–210.6 and 5.7-times increase, respectively). In the United States of America, cases of coccidioidomycosis increased between 2014 and 2017 (from 8232 to 14   364/year). National and global surveillance as well as more detailed studies to better define sequelae, risk factors, outcomes, global distribution, and trends are required. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens.

Author

Morrissey, C Orla, Kim, Hannah Y, Duong, Tra-My N, Moran, Eric, Alastruey-Izquierdo, Ana, Denning, David W, Perfect, John R, Nucci, Marcio, Chakrabarti, Arunaloke, Rickerts, Volker, Chiller, Tom M, Wahyuningsih, Retno, Hamers, Raph L, Cassini, Alessandro, Gigante, Valeria, Sati, Hatim, Alffenaar, Jan-Willem, and Beardsley, Justin

Abstract

Recognizing the growing global burden of fungal infections, the World Health Organization established a process to develop a priority list of fungal pathogens (FPPL). In this systematic review, we aimed to evaluate the epidemiology and impact of invasive infections caused by Aspergillus fumigatus to inform the first FPPL. The pre-specified criteria of mortality, inpatient care, complications and sequelae, antifungal susceptibility, risk factors, preventability, annual incidence, global distribution, and emergence were used to search for relevant articles between 1 January 2016 and 10 June 2021. Overall, 49 studies were eligible for inclusion. Azole antifungal susceptibility varied according to geographical regions. Voriconazole susceptibility rates of 22.2% were reported from the Netherlands, whereas in Brazil, Korea, India, China, and the UK, voriconazole susceptibility rates were 76%, 94.7%, 96.9%, 98.6%, and 99.7%, respectively. Cross-resistance was common with 85%, 92.8%, and 100% of voriconazole-resistant A. fumigatus isolates also resistant to itraconazole, posaconazole, and isavuconazole, respectively. The incidence of invasive aspergillosis (IA) in patients with acute leukemia was estimated at 5.84/100 patients. Six-week mortality rates in IA cases ranged from 31% to 36%. Azole resistance and hematological malignancy were poor prognostic factors. Twelve-week mortality rates were significantly higher in voriconazole-resistant than in voriconazole-susceptible IA cases (12/22 [54.5%] vs. 27/88 [30.7%]; P  = .035), and hematology patients with IA had significantly higher mortality rates compared with solid-malignancy cases who had IA (65/217 [30%] vs. 14/78 [18%]; P  = .04). Carefully designed surveillance studies linking laboratory and clinical data are required to better inform future FPPL. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.

Author

Marinelli, Tina, Kim, Hannah Yejin, Halliday, Catriona L, Garnham, Katherine, Bupha-Intr, Olivia, Dao, Aiken, Morris, Arthur J, Alastruey-Izquierdo, Ana, Colombo, Arnaldo, Rickerts, Volker, Perfect, John, Denning, David W, Nucci, Marcio, Hamers, Raph L, Cassini, Alessandro, Oladele, Rita, Sorrell, Tania C, Ramon-Pardo, Pilar, Fusire, Terence, and Chiller, Tom M

Abstract

Recognizing the growing global burden of fungal infections, the World Health Organization established a process to develop a priority list of fungal pathogens (FPPL). In this systematic review, we aimed to evaluate the epidemiology and impact of infections caused by Fusarium spp. Scedosporium spp. and Lomentospora prolificans to inform the first FPPL. PubMed and Web of Sciences databases were searched to identify studies published between January 1, 2011 and February 23, 2021, reporting on mortality, complications and sequelae, antifungal susceptibility, preventability, annual incidence, and trends. Overall, 20, 11, and 9 articles were included for Fusarium spp. Scedosporium spp. and L. prolificans , respectively. Mortality rates were high in those with invasive fusariosis, scedosporiosis, and lomentosporiosis (42.9%–66.7%, 42.4%–46.9%, and 50.0%–71.4%, respectively). Antifungal susceptibility data, based on small isolate numbers, showed high minimum inhibitory concentrations (MIC)/minimum effective concentrations for most currently available antifungal agents. The median/mode MIC for itraconazole and isavuconazole were ≥16 mg/l for all three pathogens. Based on limited data, these fungi are emerging. Invasive fusariosis increased from 0.08 cases/100 000 admissions to 0.22 cases/100   000 admissions over the time periods of 2000–2009 and 2010–2015, respectively, and in lung transplant recipients, Scedosporium spp. and L. prolificans were only detected from 2014 onwards. Global surveillance to better delineate antifungal susceptibility, risk factors, sequelae, and outcomes is required. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Outbreak of Fusarium solani Meningitis in Immunocompetent Persons Associated With Neuraxial Blockade in Durango, Mexico, 2022–2023

Author

García-Rodríguez, Gabriel, primary, Duque-Molina, Célida, additional, Kondo-Padilla, Irasema, additional, Zaragoza-Jiménez, Christian Arturo, additional, González-Cortés, Vladimir Brian, additional, Flores-Antonio, Rocio, additional, Villa-Reyes, Tania, additional, Vargas-Rubalcava, Adriana, additional, Ruano-Calderon, Luis Ángel, additional, Tinoco-Favila, Juan Carlos, additional, Sánchez-Salazar, Héctor Carlos, additional, Rivas-Ruiz, Rodolfo, additional, Castro-Escamilla, Octavio, additional, Martínez-Gamboa, Rosa Areli, additional, González-Lara, Fernanda, additional, López-Martínez, Irma, additional, Chiller, Tom M, additional, Pelayo, Rosana, additional, Bonifaz, Laura C, additional, Robledo-Aburto, Zoe, additional, and Alcocer-Varela, Jorge, additional

Published
2024
Full Text
View/download PDF

10. 969. Outbreak of Fungal Meningitis in US Patients who Received Surgical Procedures under Epidural Anesthesia in Matamoros, Mexico

Author

Smith, Dallas J, primary, Williams, Samantha, additional, Litvintseva, Anastasia P, additional, Bustamante, Nirma D, additional, Ostrosky-Zeichner, Luis, additional, Godwin, Simone, additional, Pearson, Jessica C, additional, Rivas, JulieAnna, additional, Evert, Nicole, additional, Dang, Thi, additional, Guevara, Angel, additional, Koenecke, Lori, additional, Chiller, Tom M, additional, and Gold, Jeremy A W, additional

Published
2023
Full Text
View/download PDF

11. Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey — Houston, Texas, 2017

Author

Chow, Nancy A., Toda, Mitsuru, Pennington, Audrey F., Anassi, Enock, Atmar, Robert L., Cox-Ganser, Jean M., DaSilva, Juliana, Garcia, Bobbiejean, Kontoyiannis, Dimitrios P., Ostrosky-Zeichner, Luis, Leining, Lauren M., McCarty, Jennifer, Mohajer, Mayar Al, Murthy, Bhavini Patel, Park, Ju-Hyeong, Schulte, Joann, Shuford, Jennifer A., Skrobarcek, Kimberly A., Solomon, Samantha, Strysko, Jonathan, Chiller, Tom M., Jackson, Brendan R., Chew, Ginger L., and Beer, Karlyn D.

Published
2019

12. Multistate Coccidioidomycosis Outbreak in U.S. Residents Returning from Community Service Trips to Baja California, Mexico — July–August 2018

Author

Toda, Mitsuru, Gonzalez, Francisco J., Fonseca-Ford, Maureen, Franklin, Patrick, Huntington-Frazier, Melinda, Gutelius, Bruce, Kawakami, Vance, Lunquest, Kristy, McCracken, Stephanie, Moser, Kathleen, Oltean, Hanna, Ratner, Adam J., Raybern, Chelsea, Signs, Kimberly, Zaldivar, Allison, Chiller, Tom M., Jackson, Brendan R., and McCotter, Orion

Published
2019

13. Case–Case Comparison of Candida auris Versus Other Candida Species Bloodstream Infections: Results of an Outbreak Investigation in Colombia

Author

Caceres, Diego H., Rivera, Sandra M., Armstrong, Paige A., Escandon, Patricia, Chow, Nancy A., Ovalle, Maria Victoria, Díaz, Jorge, Derado, Gordana, Salcedo, Soraya, Berrio, Indira, Espinosa-Bode, Andres, Varón, Carmen, Stuckey, Matthew J., Mariño, Adriana, Villalobos, Nohora, Lockhart, Shawn R., Chiller, Tom M., Prieto, Franklin E., and Jackson, Brendan R.

Published
2020
Full Text
View/download PDF

14. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey

Author

Adams, Eleanor, Barton, Kerri, Beer, Karlyn D, Bentz, Meghan L, Berkow, Elizabeth L, Black, Stephanie, Bradley, Kristy K, Brooks, Richard, Chaturvedi, Sudha, Clegg, Whitney, Cumming, Melissa, DeMaria, Alfred, Dotson, Nychie, Epson, Erin, Fernandez, Rafael, Fulton, Tara, Greeley, Rebecca, Jackson, Brendan, Kallen, Alexander, Kemble, Sarah, Klevens, Monina, Kuykendall, Randy, Le, Ngoc H, Leung, Vivian, Lutterloh, Emily, Mcateer, Jarred, Pacilli, Massimo, Peterson, Joyce, Quinn, Monica, Ross, Kathleen, Rozwadowski, Faye, Shannon, DJ, Skrobarcek, Kimberly A, Vallabhaneni, Snigdha, Welsh, Rory, Zhu, Yan, Chow, Nancy A, Gade, Lalitha, Tsay, Sharon V, Forsberg, Kaitlin, Greenko, Jane A, Southwick, Karen L, Barrett, Patricia M, Kerins, Janna L, Lockhart, Shawn R, Chiller, Tom M, and Litvintseva, Anastasia P

Published
2018
Full Text
View/download PDF

15. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.

Author

McKenney, Jennie, Smith, Rachel M, Chiller, Tom M, Detels, Roger, French, Audrey, Margolick, Joseph, and Klausner, Jeffrey D

Subjects
Infectious Diseases, Clinical Research, HIV/AIDS, Infection, Good Health and Well Being, AIDS-Related Opportunistic Infections, Adult, Aged, Antigens, Fungal, CD4 Lymphocyte Count, Cohort Studies, Cryptococcus, Ethnicity, Female, Humans, Male, Meningitis, Cryptococcal, Middle Aged, Prevalence, Risk Factors, United States, Young Adult, Centers for Disease Control and Prevention, General & Internal Medicine
Abstract

Cryptococcal meningitis (CM) is one of the leading opportunistic infections associated with human immunodeficiency virus (HIV) infection. The worldwide burden of CM among persons living with HIV/acquired immunodeficiency syndrome (AIDS) was estimated in 2009 to be 957,900 cases, with approximately 624,700 deaths annually. The high burden of CM globally comes despite the fact that cryptococcal antigen (CrAg) is detectable weeks before the onset of symptoms, allowing screening for cryptococcal infection and early treatment to prevent CM and CM-related mortality (2). However, few studies have been conducted in the United States to assess the prevalence of cryptococcal infection. To quantify the prevalence of undiagnosed cryptococcal infection in HIV-infected persons in the United States during 1986-2012, stored sera from 1,872 participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study with CD4 T-cell counts

Published
2014

19. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations

Author

Bongomin, Felix, Govender, Nelesh P., Chakrabarti, Arunaloke, Robert-Gangneux, Florence, Boulware, David R., Zafar, Afia, Oladele, Rita O., Richardson, Malcolm D., Gangneux, Jean-Pierre, Alastruey-Izquierdo, Ana, Bazira, Joel, Boyles, Tom H., Sarcarlal, Jahit, Nacher, Mathieu, Obayashi, Taminori, Worodria, William, Pasqualotto, Alessandro C., Meya, David B., Cheng, Ben, Sriruttan, Charlotte, Muzoora, Conrad, Kambugu, Andrew, Rodriguez Tudela, Juan Luis, Jordan, Alexander, Chiller, Tom M., and Denning, David W.

Published
2019
Full Text
View/download PDF

20. Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017

Author

Tsay, Sharon, Welsh, Rory M., Adams, Eleanor H., Chow, Nancy A., Gade, Lalitha, Berkow, Elizabeth L., Poirot, Eugenie, Lutterloh, Emily, Quinn, Monica, Chaturvedi, Sudha, Kerins, Janna, Black, Stephanie R., Kemble, Sarah K., Barrett, Patricia M., Barton, Kerri, Shannon, D.J., Bradley, Kristy, Lockhart, Shawn R., Litvintseva, Anastasia P., Moulton-Meissner, Heather, Shugart, Alicia, Kallen, Alex, Vallabhaneni, Snigdha, Chiller, Tom M., and Jackson, Brendan R.

Published
2017

21. Knowledge of Infectious Disease Specialists Regarding Aspergillosis Complicating Influenza, United States

Author

Toda, Mitsuru, Beekmann, Susan E., Polgreen, Philip M., Chiller, Tom M., Jackson, Brendan R., and Beer, Karlyn D.

Subjects
United States. Centers for Disease Control and Prevention, Hospital patients -- Health aspects, Communicable diseases -- Health aspects, Medical research -- Health aspects, Influenza -- Health aspects, Aspergillosis -- Health aspects, Immunocompromised host, Mortality, Stem cells, Chemotherapy, Cancer treatment, Surgery, Mycoses, Fungi, Pulmonary aspergillosis, Diseases, Physicians, Stem cell transplantation, Corticosteroid drugs, Health
Abstract

Invasive pulmonary aspergillosis (IPA) occurs primarily among immunocompromised patients with a history of organ or stem cell transplantation, chemotherapy, or immunosuppressive medications. However, a multicenter retrospective study in the Netherlands [...]

Published
2020
Full Text
View/download PDF

22. Investigation of the First Seven Reported Cases of Candida auris , a Globally Emerging Invasive, Multidrug-Resistant Fungus — United States, May 2013–August 2016

Author

Vallabhaneni, Snigdha, Kallen, Alex, Tsay, Sharon, Chow, Nancy, Welsh, Rory, Kerins, Janna, Kemble, Sarah K., Pacilli, Massimo, Black, Stephanie R., Landon, Emily, Ridgway, Jessica, Palmore, Tara N., Zelzany, Adrian, Adams, Eleanor H., Quinn, Monica, Chaturvedi, Sudha, Greenko, Jane, Fernandez, Rafael, Southwick, Karen, Furuya, E. Yoko, Calfee, David P., Hamula, Camille, Patel, Gopi, Barrett, Patricia, Lafaro, Patricia, Berkow, Elizabeth L., Moulton-Meissner, Heather, Noble-Wang, Judith, Fagan, Ryan P., Jackson, Brendan R., Lockhart, Shawn R., Litvintseva, Anastasia P., and Chiller, Tom M.

Published
2016

24. Trends in Agricultural Triazole Fungicide Use in the United States, 1992-2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease

Author

Toda, Mitsuru, Beer, Karlyn D., Kuivila, Kathryn M., Chiller, Tom M., and Jackson, Brendan R.

Subjects
Triazoles -- Usage -- Health aspects, Spraying and dusting in agriculture -- Environmental aspects -- Health aspects, Drug resistance in microorganisms, Mycoses -- Risk factors, Fungicides -- Usage -- Health aspects, Environmental issues, Health
Abstract

Background: The fungus Aspergillus fumigatus (A. fumigatus) is the leading cause of invasive mold infections, which cause severe disease and death in immunocompromised people. Use of triazole antifungal medications in recent decades has improved patient survival; however, triazoleresistant infections have become common in parts of Europe and are emerging in the United States. Triazoles are also a class of fungicides used in plant agriculture, and certain triazole-resistant A. fumigatus strains found causing disease in humans have been linked to environmental fungicide use. Objectives: We examined U.S. temporal and geographic trends in the use of triazole fungicides using U.S. Geological Survey agricultural pesticide use estimates. Discussion: Based on our analysis, overall tonnage of triazole fungicide use nationwide was relatively constant during 1992-2005 but increased >4-fold during 2006-2016 to 2.9 million kg in 2016. During 1992-2005, triazole fungicide use occurred mostly in orchards and grapes, wheat, and other crops, but recent increases in use have occurred primarily in wheat, corn, soybeans, and other crops, particularly in Midwest and Southeast states. We conclude that, given the chemical similarities between triazole fungicides and triazole antifungal drugs used in human medicine, increased monitoring for environmental and clinical triazole resistance in A. fumigatus would improve overall understanding of these interactions, as well as help identify strategies to mitigate development and spread of resistance. https://doi.org/10.1289/EHP7484, Background Invasive aspergillosis is a severe and frequently fatal fungal disease (mortality rate 25-59%) that most commonly affects people who are immunocompromised (e.g., because of transplantation or malignancy) or have [...]

Published
2021
Full Text
View/download PDF

25. Invasive Mold Infections Following Hurricane Harvey—Houston, Texas

Author

Toda, Mitsuru, primary, Williams, Samantha, additional, Jackson, Brendan R, additional, Wurster, Sebastian, additional, Serpa, Jose A, additional, Nigo, Masayuki, additional, Grimes, Carolyn Z, additional, Atmar, Robert L, additional, Chiller, Tom M, additional, Ostrosky-Zeichner, Luis, additional, and Kontoyiannis, Dimitrios P, additional

Published
2023
Full Text
View/download PDF

26. Candida auris: a global pathogen that has taken root in Colombia.

Author

Escandón, Patricia, Lockhart, Shawn R., Chow, Nancy A., and Chiller, Tom M.

Subjects
CANDIDA, CANDIDEMIA, EAR canal, NUCLEOTIDE sequencing, MYCOSES, WHOLE genome sequencing
Abstract

Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

27. A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria

Author

Oladele, Rita O., primary, Jordan, Alexander M., additional, Okaa, Joy U., additional, Osaigbovo, Iriagbonse I., additional, Shettima, Shuwaram A., additional, Shehu, Nathan Y., additional, Davies, Adeyinka A., additional, Mohammed, Yahaya, additional, Alex-Wele, Mary A., additional, Iliyasu, Garba, additional, Nwaokenye, Jude C., additional, Fayemiwo, Samuel A., additional, Udoh, Ubong A., additional, Gbajabiamila, Titilola, additional, Denning, David W., additional, and Chiller, Tom M., additional

Published
2023
Full Text
View/download PDF

28. Genomic description of human clinical Aspergillus fumigatus isolates, California, 2020

Author

Misas, Elizabeth, primary, Deng, John Z, additional, Gold, Jeremy A W, additional, Gade, Lalitha, additional, Nunnally, Natalie S, additional, Georgacopoulos, Ourania, additional, Bentz, Meghan, additional, Berkow, Elizabeth L, additional, Litvintseva, Anastasia P, additional, Chiller, Tom M, additional, Klausner, Jeffrey D, additional, and Chow, Nancy A, additional

Published
2023
Full Text
View/download PDF

29. LB2303. Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial

Author

Pasqualotto, Alessandro C, primary, Godoy, Cassia M, additional, Lana, Daiane Dalla, additional, Leitao, Terezinha S, additional, Bay, Monica B, additional, Damasceno, Lisandra S, additional, Soares, Renata B, additional, Falci, Diego R, additional, Kist, Roger, additional, Silva, Larissa R, additional, Melo, Marineide, additional, Guimaraes, Taiguara F, additional, Guimaraes, Marilia R, additional, Vechi, Hareton T, additional, Mesquita, Jaco, additional, Macedo, Erianna Y, additional, Adenis, Antoine A, additional, Bahr, Nathan C, additional, Spec, Andrej, additional, Boulware, David R, additional, Israelski, Dennis, additional, and Chiller, Tom M, additional

Published
2022
Full Text
View/download PDF

34. List of Contributors

Author

Abrahamian, Fredrick M., primary, Aldape, Michael J., additional, Aldasoro, Edelweiss, additional, Allen, Upton D., additional, Al-Sum, Hythem, additional, Anadkat, Milan J., additional, Anders, Katherine, additional, Angelakis, Emmanouil, additional, Angus, Brian John, additional, Antoniadou, Anastasia, additional, Arena, Fabio, additional, Arends, Joop E., additional, Arribas, Jose R., additional, Artenstein, Andrew W., additional, Atherton, John C., additional, Aucott, John N., additional, Aw, Tar-Ching, additional, Babcock, Hilary M., additional, Bailey, Robin, additional, Bailey, Thomas C., additional, Banks, Adam Z., additional, Barillo, David J., additional, Barrette, Ernie-Paul, additional, Bauer, Martijn P., additional, Bayston, Roger, additional, Beard, C. Ben, additional, Beardsley, Justin, additional, Beeching, Nick J., additional, Bégué, Rodolfo E., additional, Beldi, Guido, additional, Benson, Constance A., additional, Berbari, Elie F., additional, Berenger, Jean-Michel, additional, Berger, Christoph, additional, Bernardino, Jose I., additional, Bille, Jacques, additional, Billioux, Alexander C., additional, Bitnun, Ari, additional, Blair, Iain, additional, Blanche, Stéphane, additional, Bleck, Thomas P., additional, Bleeker-Rovers, Chantal P., additional, Bleijenberg, Gijs, additional, Bloch, Karen C., additional, Blum, Johannes, additional, Blumberg, Emily A., additional, Bonomo, Robert A., additional, Bonten, Marc J.M., additional, Bourayou, Rafik, additional, Bouza, Emilio, additional, Brandt, K. Ashley, additional, Bretelle, Florence, additional, Brisse, Sylvain, additional, Britton, Warwick J., additional, Brook, Itzhak, additional, Brouwer, Matthijs C., additional, Browne, Sarah K., additional, Bryant, Amy E., additional, Bühler, Silja, additional, Bulger, Eileen M., additional, Buller, R. Mark L., additional, Burke, Leah A., additional, Burri, Christian, additional, Butler, Marcus W., additional, Calandra, Thierry, additional, Calfee, David P., additional, Calvo-Cano, Antonia, additional, Cameron, D. William, additional, Carcillo, Joseph A., additional, Carson, Gail, additional, Chambers, Stephen T., additional, Charrel, Remi N., additional, Nguyen, Vinh Chau Van, additional, Chevaliez, Stéphane, additional, Chiller, Tom M., additional, Christaki, Eirini, additional, Chung, Kevin K., additional, Clifford, David B., additional, Clumeck, Nathan, additional, Cohen, Jonathan, additional, Collinge, John, additional, Conlon, Christopher P., additional, Conrad, Curdin, additional, Cooke, Fiona J., additional, Cope, Jennifer Rittenhouse, additional, Corey, G. Ralph, additional, Cross, John H., additional, Cunha, Burke A., additional, Cunha, Cheston B., additional, D'Journo, Benoit, additional, Daikos, George L., additional, Daniels, Johannes M.A., additional, Davidson, Robert N., additional, Day, Nicholas P.J., additional, De Cock, Kevin M., additional, de Silva, Thushan I., additional, de Vries, Henry J.C., additional, de Wit, Stéphane, additional, Delaloye, Julie, additional, Denning, David W., additional, Dennis, David T., additional, Dhanireddy, Shireesha, additional, Dielubanza, Elodi J., additional, Diemert, David J., additional, Doganay, Mehmet, additional, Doherty, Tom, additional, Dolecek, Christiane, additional, Dondorp, Arjen M., additional, Douglas, Abby, additional, Drancourt, Michel, additional, Dubourg, Grégory, additional, Dudley, Michael N., additional, Durand, Guillaume, additional, Eckhardt, Benjamin J., additional, Efstratiou, Androulla, additional, Ekkelenkamp, Miquel B., additional, Eranki, Ambika, additional, Erdem, Hakan, additional, Escota, Gerome V., additional, Evans, Heather L., additional, Eziefula, Alice Chijioke, additional, Fenollar, Florence, additional, Fenwick, Alan, additional, Fierer, Joshua, additional, Finch, Roger G., additional, Fleckenstein, James M., additional, Forstner, Christina, additional, Foschi, Federico, additional, Fournier, Pierre-Edouard, additional, French, Martyn A., additional, Gage, Kenneth L., additional, Garcia, Lynne S., additional, Gascon, Joaquim, additional, Gastañaduy, Arturo S., additional, Gautret, Philippe, additional, Geisler, William M., additional, Ghanem, Khalil G., additional, Giani, Tommaso, additional, Giannella, Maddalena, additional, Gilliam, Bruce L., additional, Gilliet, Michel, additional, Glaser, Carol A., additional, Glupczynski, Youri, additional, Gnann, John W., additional, Goldstein, Ellie J.C., additional, Gottstein, Bruno, additional, Gouriet, Frederique, additional, Gravitt, Patti E., additional, Green, Michael D., additional, Green, Stephen T., additional, Groll, Andreas H., additional, Gulick, Roy M., additional, Gupta, Arjun, additional, Habib, Gilbert, additional, Harbarth, Stephan, additional, Harris, Marianne, additional, Hayden, Frederick G., additional, Hetem, David J., additional, Hill, Philip C., additional, Hirschel, Bernard, additional, Hodowanec, Aimee C., additional, Hoffart, Louis, additional, Hoffmann, Christian, additional, Holland, Steven M., additional, Horby, Peter W., additional, Horne, David J., additional, Hraiech, Sami, additional, Hull, Mark W., additional, Huttner, Angela, additional, Ingram, Richard J.M., additional, Islam, Jasmin, additional, Ison, Michael G., additional, James, Scott H., additional, Jenkins, Claire, additional, Jenkins, Stephen G., additional, Jensen, Jørgen Skov, additional, Johnston, Christine, additional, Jones, Theodore B., additional, Jordan, Stephen J., additional, Julian, Kathleen G., additional, Kato, Yasuyuki, additional, Kauffman, Carol A., additional, Kaye, Keith S., additional, Keane, Michael P., additional, Keeney, James, additional, Kelly, Paul, additional, Kent, Stephen J., additional, Kern, Winfried V., additional, Keynan, Yoav, additional, Kim, Andrea A., additional, Koné-Paut, Isabelle, additional, Kosmidis, Chris, additional, Kroes, Aloys C.M., additional, Kroon, Frank P., additional, Ksiazek, Thomas G., additional, Kuhlmann, F. Matthew, additional, Kuijper, Ed J., additional, Kwon, Jennie H., additional, Kyei, George B., additional, Lacombe, Karine, additional, Lagacé-Wiens, Philippe, additional, Lagier, Jean-Christophe, additional, Lamagni, Theresa, additional, Landraud, Luce, additional, Lanternier, Fanny, additional, LaPlante, Kerry L., additional, Lawn, Stephen D., additional, Lawrence, Steven J., additional, Leblebicioglu, Hakan, additional, Lee, Nelson, additional, Leggett, James E., additional, Lehours, Philippe, additional, Levy, Pierre-Yves, additional, Leyh, Rainer G., additional, Lillis, Rebecca A., additional, Limmathurotsakul, Direk, additional, Lin, Jennifer, additional, Lindquist, H.D. Alan, additional, Lipsky, Benjamin A., additional, Liscynesky, Christina, additional, Looney, David, additional, Lortholary, Olivier, additional, Lowy, Franklin D., additional, Luft, Benjamin J., additional, Mackowiak, Philip A., additional, MacPherson, Paul A., additional, Maghraoui-Slim, Valérie, additional, Mallon, Patrick W., additional, Mangino, Julie E., additional, Manuel, Oriol, additional, Marchetti, Oscar, additional, Marks, Kristen M., additional, Marr, Kieren A., additional, Marrazzo, Jeanne, additional, Marschall, Jonas, additional, Martin, David H., additional, Matonti, Frédéric, additional, Matulewicz, Richard S., additional, Mayer, Kenneth H., additional, McCulloh, Russell J., additional, McGready, Rose, additional, Mdodo, Rennatus, additional, Mead, Simon, additional, Mégraud, Francis, additional, Meintjes, Graeme, additional, Metcalf, Sarah C., additional, Michaels, Marian G., additional, Migliori, Giovanni Battista, additional, Miles, Michael A., additional, Miller, Alastair, additional, Mimiaga, Matthew J., additional, Mingeot-Leclercq, Marie-Paule, additional, Misch, Elizabeth Ann, additional, Mitreva, Makedonka, additional, Montaner, Julio S.G., additional, Moore, Caroline B., additional, Muñoz, Patricia, additional, Muñoz, Jose, additional, Murray, Clinton K., additional, Musso, Didier, additional, Mutengo, Mable, additional, Mutizwa, Misha M., additional, Naber, Kurt G., additional, Natarajan, Pavithra, additional, Neme, Santiago, additional, Newton, Paul N., additional, Nichols, Ronald A., additional, Nicolle, Lindsay E., additional, Nosten, François, additional, Notarangelo, Luigi D., additional, Nutman, Thomas B., additional, Nyirjesy, Paul, additional, O'Connell, P. Ronan, additional, Opal, Steven M., additional, Ormerod, L. Peter, additional, Osmon, Douglas R., additional, Pankert, Marie Boulze, additional, Pantaleo, Giuseppe, additional, Papazian, Laurent, additional, Parente, Diane M., additional, Parola, Philippe, additional, Parsaei, Shadi, additional, Pascual, Manuel A., additional, Patel, Rupa, additional, Patrozou, Eleni, additional, Pawlotsky, Jean-Michel, additional, Peacock, Sharon J., additional, Pechère, Jean-Claude, additional, Pelegrin, Ivan, additional, Peters, Barry S., additional, Peters, Edgar J.G., additional, Petersen, Jeannine M., additional, Petersen, Lyle R., additional, Petraitis, Vidmantas, additional, Pham, Luu-Ly, additional, Picado, Albert, additional, Pilatz, Adrian, additional, Pilmis, Benoit, additional, Pinazo, María-Jesús, additional, Pletz, Mathias W., additional, Pogue, Jason M., additional, Polgreen, Evelyn L., additional, Polgreen, Philip M., additional, Posfay-Barbe, Klara M., additional, Powderly, William G., additional, Presti, Rachel, additional, Prod'hom, Guy, additional, Puolakkainen, Mirja, additional, Quinn, Thomas C., additional, Raoult, Didier, additional, Razonable, Raymund R., additional, Read, Robert C., additional, Redfield, Robert R., additional, Rentenaar, Rob J., additional, Reynolds, Steven J., additional, Ribi, Camillo, additional, Richardson, Malcolm D., additional, Ritter, Michele L., additional, Roch, Antoine, additional, Rockstroh, Jürgen Kurt, additional, Rojek, Amanda, additional, Romero, José R., additional, Rooijakkers, Suzan H.M., additional, Rosenbluth, Daniel, additional, Rosenzweig, Sergio D., additional, Rossolini, Gian Maria, additional, Rubinstein, Ethan, additional, Ryan, Greg, additional, Safren, Steven A., additional, Sahasrabuddhe, Vikrant V., additional, Saikku, Pekka A.I., additional, Sajadi, Mohammad M., additional, Salvaggio, Michelle R., additional, Santos, Carlos A.Q., additional, Satlin, Michael J., additional, Schaeffer, Anthony J., additional, Schimmer, Christoph, additional, Schooley, Robert T., additional, Schumacher, Richard F., additional, Sha, Beverly E., additional, Shapiro, Daniel S., additional, Sheehan, Gerard, additional, Shlaes, David M., additional, Shoham, Shmuel, additional, Simmons, Cameron P., additional, Simon, Dennis W., additional, Simon, Matthew S., additional, Simonsen, Kari A., additional, Slack, Mary P.E., additional, Smith, Tyrel T., additional, Sobel, Jack D., additional, Souli, Maria, additional, Sridhar, Shruti, additional, Steckelberg, James M., additional, Stevens, Dennis L., additional, Strah, Heather, additional, Sturm, A. Willem, additional, Sungkanuparph, Somnuek, additional, Tabrizi, Sarah J., additional, Tacconelli, Evelina, additional, Tan, Chen Sabrina, additional, Taplitz, Randy A., additional, Thomas, Guillemette, additional, Thomas, Lora D., additional, Thuny, Franck, additional, Thwaites, Guy, additional, Tissot, Frederic, additional, Tønjum, Tone, additional, Torriani, Francesca J., additional, Toso, Christian, additional, Tulkens, Paul M., additional, Tunkel, Allan R., additional, Turner, Claire E., additional, Ustianowski, Andrew P., additional, van Bambeke, Françoise, additional, van Crevel, Reinout, additional, van de Beek, Diederik, additional, van Delden, Christian, additional, van der Eerden, Menno M., additional, van der Meer, Jos W.M., additional, van der Poll, Tom, additional, van Ingen, Jakko, additional, van Putten, Jos, additional, Vaudaux, Bernard P., additional, Vermund, Sten H., additional, Viscidi, Raphael P., additional, Visvanathan, Kumar, additional, Visvesvara, Govinda S., additional, von Seidlein, Lorenz, additional, Wagenlehner, Florian M.E., additional, Wald, Anna, additional, Walsh, Thomas J., additional, Warhurst, David C., additional, Warnock, David W., additional, Warrell, David A., additional, Warrell, Mary J., additional, Warris, Adilia, additional, Watkins, Richard R., additional, Weatherall, David J., additional, Weber, Rainer, additional, Weidner, Wolfgang, additional, White, Jonathan R., additional, White, Peter J., additional, Whitehorn, James, additional, Whitley, Richard J., additional, Whitty, Christopher J.M., additional, Wiersinga, Willem Joost, additional, Wilcox, Mark H., additional, Williams, Thomas N., additional, Wilson, Cara C., additional, Wilson, Mary Elizabeth, additional, Wisplinghoff, Hilmar, additional, Wood, Robin, additional, Wunderink, Richard G., additional, Wyles, David, additional, Yang, Zhi-Tao, additional, Yoder, Jonathan S., additional, Zaidi, Najam A., additional, Zimmer, Andrea J., additional, Zuckerman, Jane N., additional, and Zumla, Alimuddin, additional

Published
2017
Full Text
View/download PDF

35. Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States

Author

Walker, Tiffany A., Lockhart, Shawn R., Beekmann, Susan E., Polgreen, Philip M., Santibanez, Scott, Mody, Rajal K., Beer, Karlyn D., Chiller, Tom M., and Jackson, Brendan R.

Subjects
United States. Centers for Disease Control and Prevention, Physicians -- Health aspects, Diseases -- Genetic aspects -- Care and treatment -- Health aspects, Antifungal agents -- Health aspects, Medical schools -- Health aspects, Health
Abstract

Infections with strains of Aspergillus fumigatus that are resistant to all azole antifungal medications have become common in western Europe and have been documented in other regions since 1998 (1,2), [...]

Published
2018
Full Text
View/download PDF

39. An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies.

Author

Shapiro, Adrienne E., Tenforde, Mark W., Chiller, Tom M., Ford, Nathan, and Rajasingham, Radha

Subjects
HIV infection complications, ONLINE information services, MEDICAL databases, MEDICAL information storage & retrieval systems, AMPHOTERICIN B, CONFIDENCE intervals, SYSTEMATIC reviews, CRYPTOCOCCUS neoformans, DESCRIPTIVE statistics, RESEARCH funding, MENINGITIS, DECISION making in clinical medicine, MEDLINE, FLUCONAZOLE, DISEASE risk factors
Abstract

Background: The purpose of this systematic review is to provide updated evidence on the preferred induction therapy for the treatment of HIV‐associated cryptococcal meningitis considering the most recent evidence available in order to inform the need for updates to WHO guidelines. Methods: We searched Medline via PubMed, EMBASE, the Cochrane Library and clinicaltrials.gov for published or completed randomized clinical trials that evaluated induction treatment of first episode HIV‐associated cryptococcal meningitis from 9 July 2018 (date of last search) to 1 September 2021. Results: One randomized clinical trial of 844 people with HIV‐associated cryptococcal meningitis met the inclusion criteria. Participants were randomized to: (1) amphotericin deoxycholate for 7 days, with flucytosine and fluconazole (control); or (2) a single dose of liposomal amphotericin 10 mg/kg with flucytosine and fluconazole (intervention). In the intention‐to‐treat analysis, 10‐week mortality was 24.8% [95% confidence interval (CI): 20.7–29.3%] in the single‐dose liposomal amphotericin group compared with 28.7% (95% CI: 24.4–33.4%) in the control group. The absolute difference in 10‐week mortality was −3.9% with an upper one‐sided 95% CI of 1.2%, within the 10% pre‐specified non‐inferiority margin. Fewer participants had grade 3 and 4 adverse events in the intervention arm compared with the control arm (50.0% vs. 62.3%, p < 0.001). Conclusions: In the single study included in this systematic review, single high‐dose liposomal amphotericin B with flucytosine and fluconazole was non‐inferior to the WHO‐recommended standard of care induction therapy for HIV‐associated cryptococcal meningitis, with significantly fewer adverse events. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

40. Invasive mould infections in patients from floodwater- damaged areas after hurricane Harvey – a closer look at an immunocompromised cancer patient population

Author

Wurster, Sebastian, primary, Paraskevopoulos, Timotheos, additional, Toda, Mitsuru, additional, Jiang, Ying, additional, Tarrand, Jeffrey J., additional, Williams, Samantha, additional, Chiller, Tom M., additional, Jackson, Brendan R., additional, and Kontoyiannis, Dimitrios P., additional

Published
2022
Full Text
View/download PDF

43. Reply to Hoenigl et al

Author

Kontoyiannis, Dimitrios P., Park, Benjamin J., Wannemuehler, Kathleen A., Chiller, Tom M., and Pappas, Peter G.

Published
2010

44. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

Author

Pappas, Peter G., Alexander, Barbara D., Andes, David R., Hadley, Susan, Kauffman, Carol A., Freifeld, Alison, Anaissie, Elias J., Brumble, Lisa M., Herwaldt, Loreen, Ito, James, Kontoyiannis, Dimitrios P., Lyon, G. Marshall, Marr, Kieren A., Morrison, Vicki A., Park, Benjamin J., Patterson, Thomas F., Perl, Trish M., Oster, Robert A., Schuster, Mindy G., Walker, Randall, Walsh, Thomas J., Wannemuehler, Kathleen A., and Chiller, Tom M.

Published
2010

45. Reply to Catry and Threlfall

Author

Collignon, Peter, Powers, John H., Chiller, Tom M., Aidara-Kane, Awa, and Aarestrup, Frank M.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results